Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05687110 |
|---|---|
| Brief Title: | Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes |
| First Submitted : | January 14, 2023 |
| First Submitted that Met QC Criteria : | January 14, 2023 |
| First Posted : | January 18, 2023 |
| Last Update Submitted that Met QC Criteria : | April 20, 2024 |
| Last Update Posted : | April 23, 2024 |